Accessibility navigation


The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin

Tucci, S.A. , Rogers, E.K., Korbonits, M. and Kirkham, T.C. (2004) The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin. British Journal of Pharmacology, 143 (5). pp. 520-523. ISSN 0007-1188

Full text not archived in this repository.

To link to this article DOI: 10.1038/sj.bjp.0705968

Abstract/Summary

The paraventricular nucleus (PVN) of the hypothalamus plays a key role in the control of appetite and energy balance. Both ghrelin and cannabinoid receptor agonists increase food intake when administered into this nucleus: this study investigated possible interactions between the two systems in relation to eating. The orexigenic effect of ghrelin (100 pmol) when infused in to the PVN was reversed by a small, systemic dose of the CB1 cannabinoid receptor antagonist SR141716 (1 mg kg(-1)). This is the first demonstration of a functional relationship between brain ghrelin and endocannabinoid systems, and, although it needs to be further investigated, the effect of ghrelin on food intake when injected into the PVN seems to be mediated by stimulation of cannabinoid release.

Item Type:Article
Refereed:Yes
Divisions:Faculty of Life Sciences > School of Psychology and Clinical Language Sciences
ID Code:13839
Uncontrolled Keywords:ghrelin, endocannabinoid, PVN, appetite, SR141716 , ENERGY HOMEOSTASIS, HYPOTHALAMUS, HORMONE, RATS, HYPERPHAGIA, INHIBITION, MECHANISM, PITUITARY, SR-141716, RELEASE

Centaur Editors: Update this record

Page navigation